The establishment of the first-ever global consensus for the appropriate use of intravascular ultrasound (IVUS) in lower extremity and arterial and venous interventions, results of a randomised controlled trial on community-based exercise in patients with an abdominal aortic aneurysm (AAA), and a preview of the upcoming CX Aortic Vienna Digital Edition (24–26 October, Digital) piqued readers’ interest in August.
1. Vascular experts establish appropriate use of IVUS in peripheral interventions
Royal Philips has announced an important milestone in the evolving standard of care for treating patients with peripheral vascular disease: the establishment of the first-ever global consensus for the appropriate use of IVUS in lower extremity arterial and venous interventions.
2. AngioDynamics announces FDA clearance of expanded indications for Auryon atherectomy system
AngioDynamics recently announced that it has received US Food and Drug Administration (FDA) 510(k) clearance of an expanded indication for the Auryon atherectomy system to include arterial thrombectomy.
3. JACC study makes case for expanding coverage for carotid artery stenting
Research from Ochsner Health (New Orleans, USA) published in the Journal of the American College of Cardiology (JACC) is likely to influence expanded insurance coverage for carotid artery stenting.
4. Endologix receives CE mark certification under EU-MDR for AFX2 endovascular AAA system
Endologix recently announced that is has received CE mark certification under the new EU Medical Devices Regulation (EU-MDR) for its AFX2 endovascular abdominal aortic aneurysm (AAA) system.
5. Community-based exercise programme reduces AAA morbidity and mortality in randomised trial
Results of a randomised controlled trial (RCT) point to the beneficial effects of a community-based exercise programme on outcomes in patients with an AAA.
6. Gore acquires InnAVasc Medical
Gore has announced the acquisition of InnAVasc Medical, a privately held medical technology company focused on advancing care for patients with end-stage renal disease who utilise graft circuits for dialysis treatment.
7. Safer imaging technology for complex aortic repairs uses light instead of X-rays
A new imaging device at University of Texas (UT) Southwestern (Dallas, USA) is making complex aortic repairs safer for patients and operating room staff by dramatically reducing their exposure to radiation. The device, known as Fiber Optic RealShape (FORS; Philips), uses light to visualise blood vessels, nearly eliminating the need for X-rays typically used during minimally invasive vascular procedures.
8. Smartphone video may offer non-invasive stroke screening option
Motion analysis of video recorded on a smartphone accurately detected narrowed carotid arteries, according to new research published in the Journal of the American Heart Association.
9. CX Aortic Vienna: Cardiac and vascular surgeons collaborate at the vanguard of aortic care
CX Aortic Vienna returns in October for its third edition (24–26 October, Digital), bringing together world-leading specialists from the cardiac and vascular fields to discuss all facets of aortic care from selection to investigation, diagnosis, techniques and technologies. The meeting will showcase the latest approaches—open and endovascular—for the treatment of complex aortic problems spanning the aortic valve to the iliac arteries.
10. BD launches first-in-human trial of a peripheral sirolimus drug-coated balloon
BD has announced the start of enrolment in a first-in-human trial of a peripheral sirolimus drug-coated balloon (DCB).The PREVISION trial is a prospective, multicentre, single arm, non-randomised study designed to evaluate the safety of the BD sirolimus DCB in the treatment of peripheral arterial disease (PAD) in the femoropopliteal arteries.
